Loading...
China Life Insurance Company Limited
2628.HK•HKSE
Financial Services
Insurance - Life
HK$17.90
HK$-0.06(-0.33%)
China Life Insurance Company Limited (2628.HK) Financial Performance & Statements
Review China Life Insurance Company Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-58.78%
↓ 58.78%
Operating Income Growth
841.21%
↑ 841.21%
Net Income Growth
406.56%
↑ 406.56%
Operating Cash Flow Growth
-2.43%
↓ 2.43%
Operating Margin
9.98%
↑ 9.98%
Gross Margin
100.00%
↑ 100.00%
Net Profit Margin
27.66%
↑ 27.66%
ROE
21.89%
↑ 21.89%
ROIC
0.60%
↑ 0.60%
China Life Insurance Company Limited (2628.HK) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for China Life Insurance Company Limited stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $54.66B | $190.66B | $90.86B | $86.66B |
| Cost of Revenue | $0.00 | -$99.94B | $0.00 | $0.00 |
| Gross Profit | $54.66B | $290.60B | $90.86B | $86.66B |
| Gross Profit Ratio | $1.00 | $1.52 | $1.00 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | -$23.51B | $12.78B | $1.57B | $1.34B |
| Operating Expenses | $63.10B | $113.92B | $29.69B | $20.84B |
| Total Costs & Expenses | $63.10B | $113.92B | -$72.49B | -$61.14B |
| Interest Income | $0.00 | $0.00 | $29.54B | $29.88B |
| Interest Expense | $0.00 | $112.009B | $86.76B | $89.33B |
| Depreciation & Amortization | $0.00 | -$230.00M | $1.14B | -$28.16B |
| EBITDA | $0.00 | $74.67B | $19.44B | $2.33B |
| EBITDA Ratio | $0.00 | $0.39 | $0.21 | $0.03 |
| Operating Income | -$8.44B | $74.90B | $3.22B | $2.33B |
| Operating Income Ratio | -$0.15 | $0.39 | $0.04 | $0.03 |
| Other Income/Expenses (Net) | $0.00 | $856.00M | -$3.68B | -$2.80B |
| Income Before Tax | -$8.44B | $75.75B | $17.52B | $24.07B |
| Income Before Tax Ratio | -$0.15 | $0.40 | $0.19 | $0.28 |
| Income Tax Expense | -$11.48B | $8.89B | $3.11B | $5.75B |
| Net Income | $2.41B | $66.25B | $17.63B | $20.64B |
| Net Income Ratio | $0.04 | $0.35 | $0.19 | $0.24 |
| EPS | $0.09 | $2.34 | $0.62 | $0.73 |
| Diluted EPS | $0.09 | $2.34 | $0.62 | $0.73 |
| Weighted Avg Shares Outstanding | $28.29B | $28.27B | $28.27B | $28.27B |
| Weighted Avg Shares Outstanding (Diluted) | $28.29B | $28.27B | $28.27B | $28.27B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan